Norwegian Salmon Breeders to Use New Affy Genotyping Chips to Select for Disease-Resistant Fish | GenomeWeb

Norwegian selective breeding company Aqua Gen and researchers at the Norwegian University of Life Science's Center for Integrative Genomics, or CIGENE, hope to use a custom high-density Affymetrix genotyping array to improve the breeding of Atlantic salmon.

Aqua Gen, CIGENE, and Affy disclosed the development of the new tool in a statement this week. The HD array, which contains 923,627 SNPs from the Atlantic salmon, or Salmo salar, genome, has already been used to genotype 380 samples, according to Sigbjørn Lien, CIGENE's assistant director.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.